Intellectual Property India Publishes Patent Application for 'Spirocyclic Dihydropyranopyrimidine Kras Inhibitors' Filed by Treeline Biosciences, Inc.

MUMBAI, India, July 5 -- Intellectual Property India has published a patent application (202517055551 A) filed by Treeline Biosciences, Inc., Watertown, U.S.A., on June 9, for 'spirocyclic dihydropyranopyrimidine kras inhibitors.'

Inventor(s) include Cabral, Shawn; Mascitti, Vincent; Decultot, Ludovic Jacky Gilbert; Herold, Jens-Martin; Hesp, Kevin D.; Lajiness, James Paul; Seim, Alexander E.; Tofoleanu, Florentina; and Tsai, Andy.

The application for the patent was published on July 4, under issue no. 27/2025.

According to the abstract released by the Intellectual Property India: "This disclosure provides compounds of Formula (A) (e.g., Formula (I) (e.g., Formula (I-a1), (I-a2), (I-a3), (I-a4), (I-a5), (I-b1), (I-b2), (I-b3), (I-b4), (I...